Coronary no-reflow phenomenon
Showing 1 - 25 of >10,000
ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, No-Reflow Phenomenon Trial in Tomsk (Standard therapy,
Active, not recruiting
- ST Elevation Myocardial Infarction
- +2 more
- Standard therapy
- +3 more
-
Tomsk, Tomsk Region, Russian FederationCardiology Research Institute, Tomsk NRMC
Oct 31, 2022
Coronary Microvascular Obstruction in PCI
Recruiting
- Myocardial Infarction
- No-Reflow Phenomenon
- different variants of SNPs that may be associated with the coronary microvascular obstruction development
-
Nizhny Novgorod, Nizhny Novgorod Region, Russian Federation
- +1 more
Nov 18, 2022
No-Reflow Phenomenon, Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Seoul (Nicorandil, Placebo)
Not yet recruiting
- No-Reflow Phenomenon
- +2 more
- Nicorandil
- Placebo
-
Seoul, Korea, Republic ofKorea University Anam Hospital
Aug 16, 2022
Acute Coronary Syndrome, No-Reflow Phenomenon, Normotensive Trial in Karachi (Adrenaline, Adenosine)
Completed
- Acute Coronary Syndrome
- +2 more
-
Karachi, Sindh, PakistanNational Institute of Cardiovascular Diseases
May 20, 2021
No-Reflow Phenomenon Trial (1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol)
Not yet recruiting
- No-Reflow Phenomenon
- 1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S
- (no location specified)
Apr 13, 2021
No-Reflow Phenomenon Trial (Alpha Lipoic Acid plus the standard care for post-PCI MI, The standard care for post-PCI MI)
Not yet recruiting
- No-Reflow Phenomenon
- Alpha Lipoic Acid plus the standard care for post-PCI MI
- The standard care for post-PCI MI
- (no location specified)
Apr 29, 2022
Mean Platelet Volume and STEMI Clinical Risk Scores in
Recruiting
- No-Reflow Phenomenon
- Mean platelet volume, lymphocyte number, STEMI clinical risk scores
-
Assiut, EgyptAssiut university hospital
Mar 2, 2021
STEMI, Large Thrombus Burden, No-Reflow Phenomenon Trial (Upfront preparation of microcirculation to minimize risks of no-reflow
Not yet recruiting
- STEMI
- +2 more
- Upfront preparation of microcirculation to minimize risks of no-reflow and reperfusion injury
- (no location specified)
May 26, 2022
In-hospital and Short-term Clinical Outcomes in STEMI Patients
Not yet recruiting
- STEMI
-
Assiut, EgyptAbdelrahman Ragab
Nov 3, 2023
CHA2DS2-VASc Score asPredictor of Thrombus Burden and Clinical
Not yet recruiting
- STEMI
- primary percutaneous coronary intervention
- (no location specified)
Sep 24, 2020
Predictor of No-reflow in Diabetic Patients
Not yet recruiting
- Acute Myocardial Infarction (AMI)
- 1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S
- (no location specified)
Apr 7, 2021
ST Segment Elevation Myocardial Infarction, Coronary Slow Flow Phenomenon Trial in ShangHai (Alprostadil, Nitroglycerin)
Completed
- ST Segment Elevation Myocardial Infarction
- Coronary Slow Flow Phenomenon
-
ShangHai, ChinaRen Ji Hospital Afflited to School of Medicine, Shanghai Jiao To
Mar 11, 2020
No Reflow Phenomenon Incidence and Predictors
Completed
- No Reflow Phenomenon
- STEMI
- No intervention as observational study
-
Cottingham, East Yorkshire, United KingdomCastle Hill Hospital (Hull and east Yorkshire Hospitals NHS Trus
Jul 26, 2019
STEMI Trial (PPCI in heavy thrombus burden STEMI patients)
Not yet recruiting
- STEMI
- PPCI in heavy thrombus burden STEMI patients
- (no location specified)
Mar 30, 2023
STEMI - ST Elevation Myocardial Infarction Trial in Isehara (Excimer laser catheter)
Terminated
- STEMI - ST Elevation Myocardial Infarction
- Excimer laser catheter
-
Isehara, Kanagawa, JapanTokai University School of Medicine
Sep 29, 2022
Coronary Microvascular Dysfunction Trial in Beijing (Bivalirudin, standard heparin)
Active, not recruiting
- Coronary Microvascular Dysfunction
- Bivalirudin
- standard heparin
-
Beijing, Beijing, ChinaPeking university first hospital
Aug 1, 2023
Coronary Artery Disease Trial in Helwan (Colchicine 0.5 MG Oral Tablet, Placebo)
Not yet recruiting
- Coronary Artery Disease
- Colchicine 0.5 MG Oral Tablet
- Placebo
-
Helwan, Cairo, EgyptHelwan University Hospital
Feb 13, 2023
Cardiac Ischemia, Acute Coronary Syndrome Trial in Daugavpils (PCI)
Recruiting
- Cardiac Ischemia
- Acute Coronary Syndrome
- PCI
-
Daugavpils, LatviaDaugavpils Regional Hospital
Apr 25, 2022
ST Segment Elevation Myocardial Infarction
Completed
- Factor XIII Deficiency
- +3 more
-
Padua, PD, ItalyUniversity of Padua, Cardiology Clinic
May 18, 2022
Coronary Artery Disease, Chronic Renal Failure Trial in Madrid (Percutaneous coronary intervention (PCI))
Recruiting
- Coronary Artery Disease
- Chronic Renal Failure
- Percutaneous coronary intervention (PCI)
-
Madrid, SpainLa Paz University Hospital
Apr 25, 2022
ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention Trial in Shanghai (Nicorandil, Placebo)
Recruiting
- ST Elevation Myocardial Infarction
- Percutaneous Coronary Intervention
- Nicorandil
- Placebo
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jul 26, 2022
Coronary Thrombosis Trial (Primary Percutaneous coronary angiography)
Not yet recruiting
- Coronary Thrombosis
- Primary Percutaneous coronary angiography
- (no location specified)
Dec 3, 2022
Intravascular ULTRAsound-Guided PCI in ST-Elevation Myocardial
Not yet recruiting
- STEMI
- +2 more
- IVUS imaging for primary PCI guidance
- (no location specified)
Jul 25, 2023
Post Stenting Balloon Dilatation on Coronary Microcirculation in
Completed
- ST-elevation Myocardial Infarction (STEMI)
-
Basildon, Essex, United KingdomThe Essex Cardiothoracic Centre
Aug 31, 2021
Acute Coronary Syndromes in Transitional Countries
Recruiting
- Acute Coronary Syndrome
- +3 more
-
Bologna, Emilia Romagna, ItalyUniversity of Bologna
Mar 10, 2022